What Are Common Gastrointestinal Polyposes in Children?
Discussion Bloody stools or blood in the diaper is a relatively common complaint in general pediatrics. For most patients it is often a minor concern. Commonly it is a transient problem (e.g. rectal fissure caused by constipation or trauma) or often not blood (e.g. urate crystals in the diaper, food, menses, etc.). Real blood does occur with an identifiable cause such as long distance running or heavy exercise, or milk protein allergy/sensitivity that improves with a milk-restricted diet. Many more serious causes are associated with heavier or more recalcitrant bleeding, increased defecation, abdominal pain, poor eating an...
Source: PediatricEducation.org - January 24, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

CT radiomics, machine learning predict melanoma survival
The combination of CT radiomics and machine learning can predict survival o...Read more on AuntMinnie.comRelated Reading: Radiomics model distinguishes vertebral compression fractures CT radiomics helps to predict pancreatic cancer metastases PET/CT predicts survival outcomes in immunotherapy patients PET tracer proves effective for assessing immunotherapy CT radiomics helps predict spontaneous intracerebral hemorrhage (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 21, 2022 Category: Radiology Source Type: news

Pancreatic cancer: The sign to spot when laying horizontally – ‘eased by sitting forward’
PANCREATIC cancer has one of the lowest survival rates. Sadly, around five percent of patients with the condition survive for 10 or more years. However, 37 percent of cases are preventable. The sooner a person acts, the better their chances of survival. One symptom to look out for, is in your back. (Source: Daily Express - Health)
Source: Daily Express - Health - January 16, 2022 Category: Consumer Health News Source Type: news

Signaling mechanisms in pancreatic cancer cells could provide new target for treatment
Research led by scientists at theUCLA Jonsson Comprehensive Cancer Center provides new insights into molecular “crosstalk” in pancreas cancer cells. The study, published in the journal Cell Reports, identifies vulnerabilities that could provide a target for therapeutic drugs already being studied for several different types of cancer. It was led by Dr. Caius Radu, a UCLA professor of molecular and medical pharmacology, and Dr. Timothy Donahue, a pancreatic cancer surgeon.The study centered  on an immune system signaling molecule that impairs the proliferation of cancer cells in lab studies but tends to have the oppos...
Source: UCLA Newsroom: Health Sciences - January 14, 2022 Category: Universities & Medical Training Source Type: news

Pancreatic Cancer Test Validated for Newly Diagnosed Diabetes Pancreatic Cancer Test Validated for Newly Diagnosed Diabetes
Researchers derived and validated a proprietary screening test to detect pancreatic cancer in people with new-onset diabetes. The test uses an epigenetic analysis of a 20 mL blood specimen.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 13, 2022 Category: Cancer & Oncology Tags: Diabetes & Endocrinology News Source Type: news

Minnesota Partnership awards 5 collaborative research grants for 2022
ROCHESTER, Minn. — The Minnesota Partnership for Biotechnology and Medical Genomics announced today their 2022 research awardees. This marks the partnership's 18th year of spearheading new scientific ideas from Minnesota to improve the health of, and health care for, Minnesotans. The state-funded grants for these team science proposals total nearly $5 million. This year the awards fund innovative projects on heart and liver disease, mapping diseases of the brain, congenital genetic disease, and pancreatic cancer.  These two-year… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - January 13, 2022 Category: Databases & Libraries Source Type: news

NCI Opens New Immunotherapy Clinical Trial for Mesothelioma
This study offers a reasonable chance of benefit. It would be nice to see if these patients again respond to immunotherapy.” The FDA approved Opdivo and Yervoy, an immunotherapy combination, for first-line treatment of pleural mesothelioma in 2020. It was the first new systemic approval in more than 16 years. However, it only increased the median overall survival time from 14.1 months to 18.1 months, when compared to standard chemotherapy. Find Immunotherapy Clinical Trials ...
Source: Asbestos and Mesothelioma News - January 4, 2022 Category: Environmental Health Authors: Chris Elkins Source Type: news

Pancreatic cancer symptoms: Two body parts that could be affected - warning signs
PANCREATIC cancer affects men and women in the same way and is a cancer that's found anywhere in the pancreas. What are the two body parts majorly affected by the disease? (Source: Daily Express - Health)
Source: Daily Express - Health - January 2, 2022 Category: Consumer Health News Source Type: news

Science Saturday: Identifying inherited gene mutations in pancreatic cancer can lead to targeted therapies, better survival
A new Mayo Clinic study finds 1 in 6 people with pancreatic cancer harbor inherited genetic mutations. Identifying hereditary gene mutations in pancreatic cancer can help determine individualized treatments and potentially prolong survival, according to new Mayo Clinic Center for Individualized Medicine research. In the study, which was published in Clinical and Translational Gastroenterology, nearly 1 in 6 people diagnosed with pancreatic cancer were found to have an inherited cancer-related gene mutation that likely predisposed… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 18, 2021 Category: Databases & Libraries Source Type: news

New tracer bests FDG for diagnosing liver cancer
PET/CT imaging of hepatocellular carcinoma with an experimental gallium-68-base...Read more on AuntMinnie.comRelated Reading: Sofie receives nod to start trial for PET tracer PET imaging lays foundation for new cancer therapies PET tracer shows promise for diagnosing breast cancer Sofie submits IND application for pancreatic PET agent New PET radiotracer more effective at detecting cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 10, 2021 Category: Radiology Source Type: news

Pancreatic cancer: How many times do you poo a day? The number that could indicate cancer
PANCREATIC cancer is one of the most deadliest forms of cancer, claiming thousands of lives every year in the UK. How often you poo daily may signal the deadly disease - how regular are you? (Source: Daily Express - Health)
Source: Daily Express - Health - December 2, 2021 Category: Consumer Health News Source Type: news

Additional MRI more effective for initial staging in pancreatic cancer than standard imaging and less costly
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - December 1, 2021 Category: Drugs & Pharmacology Source Type: news

Pancreatic cancer: The sign when eating - 'symptoms will often go undetected'
PANCREATIC cancer is the 10th most common cancer in the UK, accounting for three percent of all new cancer cases, according to Cancer Research UK. Pancreatic cancer is more common in older people, and in the past 10 years, pancreatic cancer rates have increased. (Source: Daily Express - Health)
Source: Daily Express - Health - November 27, 2021 Category: Consumer Health News Source Type: news

Pancreatic cancer: The ‘generalised’ feeling that could signal the deadly disease
IN THE UK there are 27 newly diagnosed cases of pancreatic cancer each day, making it the 11th most common kind of cancer. Here are the signs you can watch for that may signal a tumour in your pancreas. If you have a family history of pancreatic cancer and are over the age of 40 you may be eligible for screening. (Source: Daily Express - Health)
Source: Daily Express - Health - November 27, 2021 Category: Consumer Health News Source Type: news

Pancreatic cancer: The sign in your back of the ‘silent disease’
PANCREATIC cancer, as the name suggests, is found in the organ in your tummy called the pancreas. The pancreas release hormones and enzymes that help with food digestion and blood sugar control. Many refer to this type of cancer as the "silent disease" because its symptoms might be hard to spot. (Source: Daily Express - Health)
Source: Daily Express - Health - November 26, 2021 Category: Consumer Health News Source Type: news